Purchase Order 75N92024P00042
Award Date 12/20/23
Potential Completion Date 12/19/24
Potential Value $90K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business, for $114,000 to provide next generation sequencing on 177 genes. The contract has a completion date of November 1, 2023. Genomic Testing Cooperative is a tumor profiling laboratory that offers DNA and RNA testing for cancer biomarkers and has previously...
- The Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute awarded a firm-fixed-price purchase order contract to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business, to provide next-generation genomic sequencing test services. The $112,500 contract was awarded on August 13, 2019 and has a completion date of September 26, 2019. Genomic Testing Cooperative, a limited liability company, provides DNA and RNA...
- The National Heart, Lung and Blood Institute awarded a $24,000 purchase order contract to Genomic Testing Cooperative, LCA, a small disadvantaged business located in Lake Forest, California, for hematology panel sequencing and somatic mutation analysis services. The contract, which commenced on December 22, 2025 and extends through December 21, 2026, requires the contractor to conduct next-generation sequencing of bone marrow samples to identify somatic mutations that will provide guidance for...
- The National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $24,000 firm fixed-price purchase order contract to Genomic Testing Cooperative, LCA for hematology panel sequencing and somatic mutation analysis of bone marrow samples. The contract, awarded on July 14, 2025, with an ultimate completion date of January 14, 2026, supports the Young Lab's biomedical research initiatives by...
- The National Heart, Lung and Blood Institute (NHLBI) awarded a $24,000 firm fixed-price purchase order to Genomic Testing Cooperative, LCA, a small disadvantaged business based in Lake Forest, California, on January 20, 2026. The contract, which has no set-aside designation, requires the contractor to perform hematology panel sequencing on bone marrow samples to identify somatic mutations for the NHLBI's Young Lab. The resulting genetic analysis provides critical guidance for disease diagnosis...
- Genomic Testing Cooperative, LCA has been awarded a firm fixed price purchase order valued at fifteen thousand dollars by the Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute. The contract calls for the contractor to provide sequencing of bone marrow samples in order to aid patients' diagnosis and treatment guidance for diseases, as described in solicitation 24-007899. No set aside designation was applied to this award. Performance...
- This is a $45,000.00 firm-fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Heart, Lung and Blood Institute (NHLBI) to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business. The contract is for the provision of a 177-gene Hematology Panel, in support of NHLBI's biomedical research efforts. The contract does not have a set-aside designation. Genomic Testing Cooperative, LCA has held...
- This is a $85,500.00 firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business. The contract is for providing next-generation genomic sequence test services to support biomedical research efforts, with a focus on hematology-related research. The contract does not have a set-aside designation and is scheduled...
- This is a firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business. The contract, valued at $19,500.00, requires the contractor to provide hematology panel testing services, specifically sequencing somatic mutations in bone marrow samples, in order to provide guidance for the treatment and diagnosis of...
- This federal contract award, valued at $28,500.00, was issued by the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA (GTC), a self-certified small disadvantaged business. The contract is for the detection of somatic gene mutations in patients, which supports the NHLBI's biomedical research efforts. GTC has a history of providing genomic sequencing and testing services to the NHLBI, with previous contract...
The National Heart, Lung and Blood Institute of the National Institutes of Health, within the Department of Health and Human Services, awarded a $90,000 firm fixed price purchase order to Genomic Testing Cooperative LCA Genomic Testing Cooperative Division. The prime contractor will provide detection of somatic gene mutations in patients to the agency over a one year period of performance in Bethesda, Maryland. This contract has a total small business set aside designation. The award supports the funding agency's biomedical research efforts through analysis of patient genomic data. No major subcontractors were identified.
Generated 12/20/23, 10:25 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $90.0k | 12/19/23 |